Notice: This company has been marked as potentially delisted and may not be actively trading. NYSE:VAPO Vapotherm (VAPO) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisEarningsHeadlinesInsider TradesTrends About Vapotherm Stock (NYSE:VAPO) 30 days 90 days 365 days Advanced Chart Remove Ads Get Vapotherm alerts:Sign Up Key Stats Today's Range$2.16▼$2.1750-Day Range$2.13▼$2.1852-Week Range$0.70▼$3.44Volume51,500 shsAverage VolumeN/AMarket Capitalization$13.58 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewVapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.Read More… Remove Ads Receive VAPO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter. Email Address VAPO Stock News HeadlinesGlobal Endobronchial Valves Market Expected to Experience Strong Growth by 2031 | Exactitude ConsultancySeptember 24, 2024 | finance.yahoo.comVapotherm, Inc.: Vapotherm Announces Closing of MergerSeptember 20, 2024 | finanznachrichten.deDividendStocks for BeginnersIf you’re not familiar with how to build a strong, reliable dividend portfolio… or where to begin… We’ve got the hookup for you. A young investor who’s obsessed with dividends put together a set of 5 dividend “cheat sheets” meant to take you from 0 to what could be a full blown dividend portfolio as quickly as possible… The best part? Right now, the five dividend cheat sheets are FREEMarch 19, 2025 | ProsperityPub (Ad)Vapotherm Announces Closing of MergerSeptember 20, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VAPO, SGE, RPHM, SQSP on Behalf of ShareholdersAugust 30, 2024 | stockhouse.comVAPO Stock Earnings: Vapotherm Reported Results for Q2 2024August 13, 2024 | msn.comVapotherm Reports Second Quarter 2024 Financial ResultsAugust 12, 2024 | prnewswire.comPLPL Plandaí Biotechnology, Inc.July 28, 2024 | seekingalpha.comSee More Headlines VAPO Stock Analysis - Frequently Asked Questions How were Vapotherm's earnings last quarter? Vapotherm, Inc. (NYSE:VAPO) released its quarterly earnings results on Wednesday, November, 3rd. The company reported ($4.16) earnings per share for the quarter, missing analysts' consensus estimates of ($4.00) by $0.16. The firm had revenue of $38.12 million for the quarter, compared to analyst estimates of $32.56 million. When did Vapotherm's stock split? Shares of Vapotherm reverse split before market open on Friday, August 18th 2023. The 1-8 reverse split was announced on Friday, August 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. When did Vapotherm IPO? Vapotherm (VAPO) raised $60 million in an initial public offering on Wednesday, November 14th 2018. The company issued 4,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. What other stocks do shareholders of Vapotherm own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vapotherm investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Uber Technologies (UBER) and Adobe (ADBE). Company Calendar Last Earnings11/03/2021Today3/19/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:VAPO CIK1253176 Webwww.vapotherm.com Phone(866) 410-9986FaxN/AEmployees290Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($8.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-58,190,000.00 Net Margins-76.74% Pretax Margin-76.57% Return on EquityN/A Return on Assets-68.08% Debt Debt-to-Equity RatioN/A Current Ratio0.25 Quick Ratio0.09 Sales & Book Value Annual Sales$68.67 million Price / Sales0.20 Cash FlowN/A Price / Cash FlowN/A Book Value($9.01) per share Price / Book-0.24Miscellaneous Outstanding Shares6,260,000Free Float5,273,000Market Cap$13.58 million OptionableNo Data Beta-1.11 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NYSE:VAPO) was last updated on 3/19/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vapotherm, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vapotherm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.